Common Drug Review


Health Economics

  • A Canadian organization that is part of the Canadian Agency for Drugs and Technologies in Health, which provides participating federal, provincial and territorial drug benefit plans with systematic reviews of the best available clinical evidence, critiques of manufacturer-submitted pharmacoeconomic studies and formulary listing recommendations made by the Canadian Expert Drug Advisory Committee.
  • acronymCDR